DADC
RDY icon

D.A. Davidson & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

D.A. Davidson & Co’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-500
Closed -$4K – 2175
2013
Q4 		$4K Buy
+500
New +$3.96K ﹤0.01% 1897

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

D.A. Davidson & Co's RDY Position: Q1 2014 in Review

D.A. Davidson & Co sold out of Dr. Reddy's Laboratories (RDY) in Q1 2014, closing a stake of 500 shares — an estimated $4K sold.

D.A. Davidson & Co first reported a position in RDY in Q4 2013 and held it in 1 quarter. The position peaked at $4K in Q4 2013. 165 funds tracked by Wall St. Rank hold RDY as of Q1 2014.

  • D.A. Davidson & Co reported no remaining Dr. Reddy's Laboratories position as of Q1 2014 after selling out during the quarter.
  • D.A. Davidson & Co sold 500 Dr. Reddy's Laboratories shares in Q1 2014, an estimated $4K.
  • D.A. Davidson & Co first reported a position in Dr. Reddy's Laboratories in Q4 2013 and held it in 1 quarter.
  • D.A. Davidson & Co's Dr. Reddy's Laboratories position peaked at $4K in Q4 2013.
  • 165 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2014.

Based on D.A. Davidson & Co's 13F filing for Q1 2014, filed 5 May 2014.